The Efficacy and Safety of Brinzolamide 1% Ophthalmic Suspension (Azopt®) as a Primary Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
- 31 January 2000
- journal article
- clinical trial
- Published by Elsevier in Survey of Ophthalmology
- Vol. 44, S155-S162
- https://doi.org/10.1016/s0039-6257(99)00107-1
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: